JP2021517805A5 - - Google Patents
Info
- Publication number
- JP2021517805A5 JP2021517805A5 JP2020543750A JP2020543750A JP2021517805A5 JP 2021517805 A5 JP2021517805 A5 JP 2021517805A5 JP 2020543750 A JP2020543750 A JP 2020543750A JP 2020543750 A JP2020543750 A JP 2020543750A JP 2021517805 A5 JP2021517805 A5 JP 2021517805A5
- Authority
- JP
- Japan
- Prior art keywords
- monoclonal antibody
- population
- mammalian host
- fucosylated
- cell culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862630971P | 2018-02-15 | 2018-02-15 | |
| US62/630,971 | 2018-02-15 | ||
| PCT/US2019/018169 WO2019161167A1 (en) | 2018-02-15 | 2019-02-15 | Process for producing hu14.18k322a monoclonal antibody |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021517805A JP2021517805A (ja) | 2021-07-29 |
| JP2021517805A5 true JP2021517805A5 (enExample) | 2022-02-24 |
Family
ID=67620073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543750A Ceased JP2021517805A (ja) | 2018-02-15 | 2019-02-15 | Ｈｕ１４．１８Ｋ３２２Ａモノクローナル抗体を産生するためのプロセス |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210002384A1 (enExample) |
| EP (1) | EP3752535A4 (enExample) |
| JP (1) | JP2021517805A (enExample) |
| KR (1) | KR20200123156A (enExample) |
| CN (1) | CN112105647A (enExample) |
| AU (1) | AU2019220667A1 (enExample) |
| CA (1) | CA3091344A1 (enExample) |
| IL (2) | IL276211B2 (enExample) |
| WO (1) | WO2019161167A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7494722B2 (ja) * | 2020-12-16 | 2024-06-04 | 株式会社島津製作所 | 糖鎖質量分析データ解析装置、及び糖鎖質量分析データ解析用プログラム |
| EP4531918A2 (en) * | 2022-06-01 | 2025-04-09 | TG Therapeutics Inc. | Commercial-scale recombinant protein production in rat hybridoma cells |
| WO2024040194A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
| CN115894604B (zh) * | 2022-12-16 | 2024-01-23 | 康日百奥生物科技(苏州)有限公司 | 重组蛋白澄清纯化方法 |
| AU2024279278A1 (en) | 2023-05-31 | 2025-12-18 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| US20250127728A1 (en) | 2023-10-05 | 2025-04-24 | Capstan Therapeutics, Inc. | Constrained Ionizable Cationic Lipids and Lipid Nanoparticles |
| WO2025076113A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Ionizable cationic lipids with conserved spacing and lipid nanoparticles |
| WO2025217452A1 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| WO2025217454A2 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Ionizable cationic lipids and lipid nanoparticles |
-
2019
- 2019-02-15 EP EP19754295.4A patent/EP3752535A4/en not_active Withdrawn
- 2019-02-15 IL IL276211A patent/IL276211B2/en unknown
- 2019-02-15 JP JP2020543750A patent/JP2021517805A/ja not_active Ceased
- 2019-02-15 KR KR1020207026156A patent/KR20200123156A/ko not_active Ceased
- 2019-02-15 IL IL315353A patent/IL315353A/en unknown
- 2019-02-15 CA CA3091344A patent/CA3091344A1/en active Pending
- 2019-02-15 AU AU2019220667A patent/AU2019220667A1/en not_active Abandoned
- 2019-02-15 US US16/969,733 patent/US20210002384A1/en not_active Abandoned
- 2019-02-15 CN CN201980013212.4A patent/CN112105647A/zh active Pending
- 2019-02-15 WO PCT/US2019/018169 patent/WO2019161167A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021517805A5 (enExample) | ||
| TW426734B (en) | A mammalian cell culture process for controlling the sialic acid content of a glycoprotein | |
| JP2025098016A (ja) | 細胞培養において産生される抗体の総非フコシル化グリコフォームの調節 | |
| IL276211B2 (en) | HU14.18K322A monoclonal antibody production process | |
| JP2021524270A5 (enExample) | ||
| JP2014506790A5 (enExample) | ||
| JP2011004753A5 (enExample) | ||
| RU2010101024A (ru) | Способ синтеза белка с модифицированным профилем n-гликозилирования в растениях | |
| TWI910092B (zh) | 供製備糖蛋白之細胞培養方法 | |
| JP2014505012A5 (enExample) | ||
| KR20150138273A (ko) | 단백질의 피로글루타민산 형성을 증가시키기 위한 방법 | |
| JP2025120179A5 (enExample) | ||
| JP2014530609A5 (enExample) | ||
| CN101413002A (zh) | 表达抗体或抗体类似物的重组克鲁维酵母菌及其构建方法与应用 | |
| Steinhardt et al. | Fab-arm exchange combined with selective protein a purification results in a platform for rapid preparation of monovalent bispecific antibodies directly from culture media | |
| KR102167727B1 (ko) | 드로소필라 멜라노개스터 s2를 이용한 메르스 항원 단백질 생산방법 | |
| US20240279704A1 (en) | Using fucosidase to control afucosylation level of glycosylated proteins | |
| CN113201069B (zh) | mcherry或mEOS纳米抗体及其制备方法和应用 | |
| TW202241924A (zh) | 一種雙特異性抗體的純化方法 | |
| CN119874849B (zh) | 一种湿地病毒糖蛋白Gc的疫苗及其应用 | |
| RU2407796C2 (ru) | КОНСТРУКЦИИ СЛИЯНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ АНТИТЕЛ С ПОВЫШЕННЫМИ АФФИННОСТЬЮ СВЯЗЫВАНИЯ Fc-РЕЦЕПТОРА И ЭФФЕКТОРНОЙ ФУНКЦИЕЙ | |
| Tan et al. | Expression and purification of a secreted functional mouse/human chimaeric antibody against bacterial endotoxin in baculovirus‐infected insect cells | |
| JPS61221128A (ja) | プラスミノ−ゲン活性化因子に対するモノクロ−ナル抗体とその調製方法及び該モノクロ−ナル抗体の使用方法 | |
| KR101411788B1 (ko) | 기능성 단백질 생산용 미생물 숙주세포를 제조하는 방법 | |
| JP2022545947A5 (enExample) |